CT Scans Unleash A Breakthrough In Catching Early Stage Lung Cancer
6/30/2011
The National Lung Screening Trial (NLST) is the first scientific study that provides clear evidence that CT screening significantly reduces the death rate due to lung cancer. NLST data shows 20 percent fewer lung cancer deaths among trial participants who had the CT scan compared with the chest x-ray...
UT MD Anderson Debuts Lung Cancer Screening Program
6/30/2011
Current and former heavy smokers can now be screened more effectively for lung cancer. Results from the National Lung Screening Trial (NLST) revealed that detecting small lung cancers with computed tomography (CT) reduces lung cancer specific mortality by 20 percent...
Blocking Molecular Target Could Make More Cancers Treatable With PARP Inhibitors
6/30/2011
Researchers at Dana-Farber Cancer Institute have demonstrated a molecular strategy they say could make a much larger variety of tumors treatable with PARP inhibitors, a promising new class of cancer drugs...
Current or heavy smokers who were screened with low-dose spiral computed tomography (CT) scanning had a 20 percent reduction in deaths from lung cancer than did those who were screened by chest X-ray, according to results from a decade-long, large clinical trial that involved more than 53,000 people...
Novel tools and methods for delivering therapeutic genes to cells in the central nervous system hold great promise for the development of new treatments to combat incurable neurologic diseases...
Project To Accelerate Targeted Cancer Therapies
6/30/2011
The Scripps Translational Science Institute (STSI) of San Diego, Calif., has joined a national consortium of research institutions headed by The Jackson Laboratory (JAX) that is building a library of primary human tumors with the goal of developing highly targeted cancer therapies...
ESC Calls For Greater Awareness Of Potential For Adverse Events From Bleeding As A Result Of PCI
6/30/2011
The European Society of Cardiology (ESC) Working Group on Thrombosis is calling for greater attention to be paid by health care staff to reducing bleeding in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary interventions (PCI), and for increased research in the field...
Ovarian Cancer Breakthrough Found In Cellular Enzyme That Switches On Resistance To Chemo Drugs
6/29/2011
The discovery that a cellular enzyme switches on a gene that makes ovarian cancer cells resist the most commonly used chemotherapy drugs, is being heralded as a significant breakthrough, with the hope it will lead to new treatments that prolong survival for women in the advanced stages of a disease that currently has a very poor outlook...
Scientists Identify Order Of Mutations That Lead To Cancer
6/29/2011
Scientists have begun to reveal the order of the genetic aberrations in individual cancers in a finding they say is key to early diagnosis and personalized medicine. "We know that each cancer is a collection of genetic malfunctions," said Raymond Cho, Ph.D., an assistant clinical professor in the department of dermatology at the University of California, San Francisco (UCSF)...
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced that data and study design features on PV-10 for metastatic melanoma were presented at two separate conferences. Data was presented by two of Provectus's Principal Investigators for the Phase 2 melanoma study, Dr. Sanjiv Agarwala, M.D...